The isolated perfused heart has been used increasingly during the last decade as a model for identifying actions of drugs on ventricular fibrillation (VF) induced by myocardial ischaemia. In addition, it has been used to explore the mechanisms responsible for the initiation and maintenance of VF, the concept of endogenous myocardial protection and the phenomenon of preconditioning. This article is a review of the available data (effects of drugs, sources of variation, comparison with other models and man, etc.) and an attempt to evaluate the possible clinical relevance. For several reasons, it is not possible to make a precise judgement on the absolute value of the model in terms of its ability to accurately predict the effectiveness of drugs in the prevention of sudden cardiac death, the main reason being the lack of a positive control, i.e. a drug with proven effectiveness against sudden cardiac death caused by VF in man. Nevertheless, the means by which one may reliably and reproducibly generate ischaemia-induced VF in different isolated heart preparations, and the factors (such as species, heart rate, perfusion constituents and involved zone size) that determine the incidence of VF are now well documented. Careful selection of species and experimental conditions permits the isolated heart of smaller inexpensive animals to function as a first line model for detecting anti-VF activity of probable relevance to phase 1 arrhythmogenesis (i.e., arrhythmogenesis during the first 30 min of ischaemia). In view of the absence of a clinical template from which to evaluate how well it predicts drug effectiveness in man, this model's clinical relevance, like that of all other preparations and models, can yet be neither accepted nor dismissed. Recent publication patterns suggest an increasing use of the model. Therefore, recommendations are made to facilitate its effective use.
Methods
much data that has been published only in abstract form (and one suspects much other data that has not been, and Data included in this article were assembled from never will be, published in any form). By contrast, more personal archives (covering publications pre-1980) and an cumbersome preparations, including most in vivo models on-line literature search using pairs of search terms from (especially those utilising large animals such as dogs, cats the following: in vitro, isolated, fibrillation, arrhythmia and and pigs) that generate data more slowly (and expensiveischaemia. To avoid selection bias, all 'full' publications ly), generally give rise to a full publication each time a on drug suppression of VF induced by ischaemia in drug is tested (at the very least, in order to express publicly isolated heart preparations have been cited. If there are any some justification for undertaking the experiment). In this omissions, this is by oversight rather than design. The article, the numerous abstracts on arrhythmias in isolated isolated heart has been used extensively by the pharmahearts have been ignored, since the extent of peer review is ceutical industry as a first line screen (both in-house and not possible to determine in every instance. Articles that via external collaboration). As a consequence, there is mention VF en passant have been cited only if they provide numerical data on the incidence of VF. Articles asystole is prevented by SA and AV nodal superfusion that present only combined VF plus ventricular tachycardia during zero flow global ventricular ischaemia, the inci-(VT) incidences or do not give actual VF incidence data dence of VF remains close to zero [6] . This could be have not been included in the survey of drug effects.
interpreted to imply that some residual flow in the ventricle is required for the initiation of ischaemia-induced VF, although there are other data that do not support this (see 2. Historical overview later). Global ischaemia preparations have not achieved widespread use for the study of ischaemia-induced VF and Ischaemia-induced VF was first described in an isolated fewer than ten full publications have appeared to date. heart by Gunn [1] . Fibrillar contraction (electrogram Regional ischaemia in isolated hearts is today a more recording was not made) was elicited by an air embolism widespread technique for examining ischaemia-induced introduced into the coronary vasculature. The candid VF. However, the first full publication, from Hearse's reporting in the article acknowledged a tendency for the group, appeared only in 1985 [10] . In this study, an perfused heart to develop VF spontaneously (the perfusion attempt was made to raise baseline VF incidence in the rat solution was glucose-free, and coronary flow values were Langendorff preparation by perfusing with adrenaline or not reported), and there was no attempt to discriminate forskolin, in order to explore the role of cAMP as an quantitatively between embolism-induced VF and spontaendogenous mediator of VF. To achieve this end, a low neous (presumably injured-preparation-induced) VF. One baseline control incidence of VF was a necessary preanecdote demonstrates VF apparently induced within 10 s requisite. The control incidence of VF was indeed low by an air embolus [1] . Having on occasion unfortunately (8%), but this would be considered anomalous for the rat allowed air to pass through the coronary circulation of the Langendorff preparation today (see Table 1 ). In the light of 1 isolated rat heart without eliciting so much as a ventricular present knowledge [5] , the high perfusate K concenpremature beat (VPB), one is inclined to regard this early tration used (6.5 mequiv. / l) can be expected to have anecdotal report as unreliable. It has gone largely uncontributed to the low control incidence of VF. noticed.
Regional ischaemia in the isolated heart is commonly Despite an awareness of ischaemia-induced VF, and the achieved by sewing a suture under the left anterior emergence over several decades of a variety of in vivo descending (or, in rat, left main) coronary artery close to preparations for its study [2] , there was no mention again its origin, and compressing the artery against tubing of ischaemia-induced VF in the isolated heart until the mid through which the suture is threaded to effect a ligature, in 1970s. In 1975, Opie's group [3] attempted left coronary a manner akin to that used in vivo [11] . Since the early artery ligation in the isolated working rat heart preparation.
1990s, there has been an increase in the use of the rat Ligation was achieved by adapting a technique used in Langendorff preparation for exploring ischaemia-induced vivo for small animals, originally described in the 1940s VF (more than 30 publications to date), whereas the other [4] . None of the hearts in Opie's study developed VF or isolated heart preparations, rat, guinea pig and rabbit VT during 60 min regional ischaemia. In this study, global ischaemia, and rabbit and marmoset regional iscoronary ligation lowered coronary flow by only 27%, and chaemia, have been used less than fifteen times collective- Krebs' solution (K 55.9 mequiv. / l) was used to perfuse ly. Fig. 1 shows the accumulated use of the rat Langenthe hearts. Today, we know that the extent of flow dorff regional ischaemia preparation. reduction indicates the extent of the involved region, and
In addition there are six-sixteen publications for each of 1 both this and the K content of the perfusion solution the following: rat working heart with regional ischaemia, determine the likelihood (incidence) of VF in isolated rat global ischaemia (working and Langendorff perfusion hearts [5, 6] , as discussed in more detail later. In the light mode) and fewer than five publications each for guinea pig of this knowledge, Opie's protocol [3] would not be global ischaemia (working and Langendorff perfusion expected to give rise to severe ischaemia-induced arrhythmode), rabbit regional ischaemia and marmoset regional mias.
ischaemia. Three years after this first study, Bricknell and Opie [7] One of the more puzzling aspects of the use of isolated subjected rat hearts to an 85% reduction in global coronary hearts for generating ischaemia-induced VF is the late flow as part of a series of experiments on cardiac biochemappearance of the model in comparison with others. In istry during ischaemia (and reperfusion). They observed particular, coronary ligation-induced VF in large animals, that none of the hearts fibrillated during ischaemia. Today, first described in the latter part of the last century, was an we know that low flow global ischaemia can be effected in established technique by the 1940s, particularly as a result rat hearts to cause VF in 80-90% of controls if coronary of the work of Harris [12] . There may be several explanaflow is reduced by more than 85% [8] . Interestingly, in tions. First, until the 1970s, it had been possible to carry zero flow preparations, VF incidence is close to zero [9] . out in vivo experiments in large animals inexpensively and Zero flow global ischaemia causes asystole, whereas sinus without the need for the kind of complex ethical approval rhythm may persist if some flow is maintained but, even if required in most countries today. Therefore, there had been 6-OHDA56-hydroxydopamine sufficient to reduce cardiac noradrenaline content; i.c.5intracardiac; L5Langendorff model; low flow5global reduction in flow to below 5% of control; W5working heart model; VF5ventricular fibrillation; ↓5reduction; ↑5increase; an effect is a significant change in the incidence of VF.
little motivation to develop isolated heart models. Second, VF. We now know that although data for most small hearts from small animals (those most suitable for conanimals is scanty, in male rats at least, coronary ligation venient in vitro perfusion) were perceived to be resistant to elicits VF highly reproducibly in vivo [14] . Additionally, to the development of ischaemia-induced VF. In a study of ligate a large coronary artery in a small animal heart ligation of coronary arteries in vivo in rats, hamsters and requires an act of faith. The large arteries are not visible to mice, performed in 1954, it was stated that VF did not the naked eye in perfused preparations, and ligation occur [13] . Unfortunately, in this study, the ECG was not requires prior knowledge of where the arteries are located. recorded and the chest was closed immediately after Moreover, their small size means that coronary arteries can coronary ligation, preventing even 'visual' detection of neither be conveniently isolated nor ligated without the inclusion of cardiac muscle within the occluding snare. Despite evidence that ensnaring muscle alone does not cause infarction [13] , these anticipated difficulties may have been sufficient to put off investigators from using isolated hearts (from small animals). Today we know that not only can an involved region be produced simply by coronary ligation in a small animal's isolated heart, but also that the size of the involved zone can be varied precisely and accurately by choosing different sites for placement of the occlusive snare [6, 15] . Following the first clear description of coronary ligationinduced VF in small animals (rats) in vivo [16] , and the increasing use of isolated hearts for metabolic studies (e.g., [7] ), an emerging interest in oxygen-derived free radicals and their role in reperfusion-induced injury stimulated the use of isolated hearts in the examination of reperfusioninduced VF (see Manning and Hearse, [17] ). Since reperfusion requires that there is ischaemia beforehand, the isolated heart subsequently became used for the study of ischaemia-induced VF. Once factors influencing the sus- ceptibility to ischaemia-induced VF in isolated hearts had eventually been characterised (e.g., [5, 6, 18] ), the preparamust exhibit two key characteristics; a control incidence of tion finally came of age in the 1990s, when, for the first VF that is sufficiently high to allow detection of protective time, Circulation and Circulation Research published work drug actions with precision but without the need for more on new approaches to suppression of ischaemia-induced than ten-twelve preparations per group, and a control VF that utilised the isolated perfused heart from different incidence of VF that varies little between studies, to permit species [19] [20] [21] .
accurate detection of drug action. Bioassay characteristics Due to an apparent lack of awareness of the strong of isolated heart preparations have been defined or may be 1 influence of certain factors (such as K ) on susceptibility deduced from the literature (which is extensive in the case to ischaemia-induced VF in earlier studies, and the relaof the rat Langendorff preparation). Tables 1-4 summarise tively small number of studies that have been performed to control VF incidences and responses to drugs during date, it is difficult to fully evaluate the principal issues ischaemia in the isolated heart. There appears to be a wide (i.e., bioassay characteristics and potential clinical relerange of values. However, this can be explained by vance) that determine the suitability of the available consideration of the sources of variation. isolated heart preparations, with one exception, the rat Langendorff regional ischaemia preparation, which has 3.2. Sources of variation been used fairly extensively for detecting anti-VF actions 1 of drugs [8, 19, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] , and is well characterised [5, 6, 18] .
3.2.1. Perfusion K content The study of VF in globally ischaemic hearts came One important source of variation is the constituents of 1 about from the use of the preparation to study the the control perfusion solution. The control K content has metabolic effects of ischaemia [7] . Global ischaemia can varied between studies from 2.7 [41] to 6.5 mequiv. / l [10] . be achieved simply by clamping the aortic cannula Standard Krebs' solution contains 5.9 mequiv. / l K . In 1 (Langendorff preparation) or the left atrial cannula (worktwo studies, it has been demonstrated that variation of K ing heart preparation). However, one would not instinctivecontent between 2 and 8 mequiv. / l can change VF ly choose a global ischaemia preparation if the study of VF incidence during ischaemia from 100 to 0% [5, 29] . This is 1 related to ischaemic heart disease were the primary objecsimilar to the relationship between blood K content and tive (global ischaemia is liable to be encountered in man the prevalence of sudden cardiac death in patients with only during cardiopulmonary bypass, or once VF has ischaemic heart disease [42-44]. begun). On the other hand, any study of ischaemia or reperfusion that requires the use of the guinea pig must use 3.2.2. Involved (ischaemic) zone size global rather than regional ischaemia, due to the extensive Another important source of variation is the size of the collateral vascularisation of the guinea pig heart, which involved zone. VF occurring during regional ischaemia was precludes the production of regional ischaemia by single reported to exhibit a bell-shaped relationship with involved arterial ligation [37] . The majority of such studies have zone size, with maximum susceptibility occurring when utilised low flow rather than zero flow global ischaemia approximately 50% of the combined weight of the left and (e.g., [38] ). One reason for this is that zero flow global right ventricles was involved [6] . In rabbit and marmoset ischaemia causes sinus arrest, AV block and asystole and hearts, the control incidence of ischaemia-induced VF was very little VF in the isolated heart [6] , whereas low flow found to be low, even with a large (40%) involved zone ischaemia causes sufficient VF to allow detection of antisize and clear evidence of ischaemia, as indicated by the VF drug action in some, although not all, studies (Table  observation that more than 50% of hearts developed VF 1).
during subsequent reperfusion [20] . The relationship beThe dual perfusion preparation [39] is a recent moditween VF susceptibility and involved zone size in man is fication of the isolated heart model of ischaemia-induced not known. Experiments in vivo using rats [14] and dogs VF. This technique makes use of a dual lumen catheter that [45] have demonstrated a relationship that is qualitatively allows independent perfusion of left and right coronary similar to that for Langendorff perfused rat hearts. The beds. Left regional ischaemia can be elicited without the reason why ischaemia-induced VF exhibits a bell-shaped need for coronary artery ligation, and the site of action of relationship with involved zone size is intriguing and may anti-VF drugs can be determined by selective perfusion of indicate that ischaemia-induced VF initiates via an interthe left or right coronary beds with a test solution [40] .
action between involved and uninvolved regions, perhaps via flow of injury current [6] .
Bioassay characteristics 3.2.Depth of ischaemia
The depth (severity) of ischaemia within the involved 3.1. Bioassay requirements zone also determines VF incidence. Experiments performed in vivo on dogs, which show a wide variation in Any experimental preparation intended for use in excollateral supply to the involved zone, have revealed that amining the actions of drugs on ischaemia-induced VF residual flow is an important source of variation for L5Langendorff model; low flow5global reduction in flow to below 5% of control; W5working heart model; VF5ventricular fibrillation; ↓5reduction; ↑5increase; an effect is a significant change in the incidence of VF.
ischaemia-induced VF [46] . The rat and rabbit heart [37] mean rates for isolated rat, guinea pig and rabbit hearts are and also the marmoset [20] exhibit a low level of residual about 280, 190 and 180 beats / min, respectively [20, 38] . flow, amounting to less than 6% of uninvolved zone flow. This minimises variation in the depth of ischaemia. A 3.3. Natural history: Phase 1a and phase 1b VF within-laboratory assessment of data from conscious rats over a period of several years revealed that the control
The time-course of appearance of ischaemia-induced VF incidence of VF was both reproducible and high [14] , and is an important characteristic of a preparation. Its complexthis may be attributable to the consistent level and low ity, species-, model-and condition-dependence and its level, respectively, of residual flow [37] .
relationship to the human disease are discussed below.
3.2.4.
Heart rate 3.3.1. Human template Heart rate is an important source of variation. The onset
Estimates of VF natural history in man are not precise as of ischaemia-induced VF is delayed by bradycardia [18] . they generally provide only the incidence within the first When a study is time-limited (30 min ischaemia is hour of symptoms. Nor are they accurate, since they do not commonly used for the study of phase 1 arrhythmias), VF include patients who die from VF before being seen by a incidence may become very low if the heart rate is slow physician (i.e., outside of hospital, the main sub-population [18], precluding detection of anti-VF drug action. In global that dies from VF). The time-course during the first 30 min ischaemia studies, bradycardia is an inevitable conseof ischaemia is unknown; indeed, the time-course over quence of SA and AV nodal ischaemia. Because heart rate several hours after the onset of ischaemia is sketchy, due to is species-dependent, optimum heart rates are also speciesuncertainty over the exact time of onset of ischaemia, and dependent. Sinus rate is lower in crystalloid (blood-free) the variable presence of drugs, even in the low percentage perfused hearts than it is in vivo, even when temperature of patients that get to see a physician during the interval and other sources of variation are controlled (see later for between the onset of symptoms and sudden cardiac death details on model refinement, Section 4). Characteristic [47] [48] [49] . There is even variation between the few studies Compound 202-7915isopropyl 4-(2,1,3-benzoxadiazo-4-yl)-1,4-dihydro-2,6-dimethyl-5-nitro-3-pyridine-carboxylate; L5Langendorff model; low flow5 global reduction in flow to below 5% of control; W5working heart model; VF5ventricular fibrillation; ↓5reduction; ↑5increase; an effect is a significant change in the incidence of VF.
that have reported incidences of in-hospital VF recorded man. It remains to be determined whether phase 1 is monoduring the first hour after the onset of chest pain, e.g., from or bimodal, and if there is a separation between phase 1 2 [47] to 10% [50] .
VF (occurring during the first 30 min of ischaemia) and Because of this lack of precision and accuracy, Fig. 2a phase 2 VF (occurring later). The relationship in man indicates that the profile of phase 1 VF is not known in between phase 1 VF and involved zone size, collateral 
L5Langendorff model; low flow5global reduction in flow to below 5% of control unless stated; VF5ventricular fibrillation; ↓5reduction; ↑5increase; an effect is a significant change in the incidence of VF. Fig. 2 . Time-course of phase 1 ischaemia-induced VF in man and a different primate, rat and guinea pig whole heart preparations, in vivo and in vitro. The methods for obtaining the data, the anaesthetics used (in vivo studies) and other methodological considerations are described in the text. The source material was: references [50] and [47] (part a), [53] (part b), [103] (part c), [104] (part d), accumulated unpublished data from 40 consecutive control hearts
from my laboratory, hearts perfused with Krebs' modified to contain 3 mequiv. / l K and 1.4 mequiv. / l Ca (part e), [20] (part f), [9] (part g) and [38] (part h). [51] in onset. In Figs. 2-4 , the time-course of phase 1 VF onset anaesthetised dog, were defined as occurring 2-10 and has been recalculated using data derived from original 12-30 min after the start of ischaemia. Likewise, the publications, taking into account animal deaths and (in the 'phase 1a' and '1b' arrhythmias described by Meesman et case of rat experiments) fluctuations in group size associal. [46] in the same model were those occurring before and ated with transient VF or defibrillation. In order to generate after the twelfth minute of ischaemia. The terms 'phase 1a'
figures that can be contrasted, the group incidence of new and '1b' were coined on the basis of the arrhythmia episodes of VF was calculated for the sequential time time-course that had been observed in a model. Importantintervals, 0-1, 1-2, 2-5, 5-10, 10-15....25-30 min after ly, the terms were not coined on the basis of any forethe onset of ischaemia for each model. The data should knowledge of the possible existence of discrete mechastrictly have been represented by histograms, but curves nisms of initiation of VF at different times after the onset were drawn instead for illustrative purposes. In each of ischaemia. Although there is some evidence that phase instance, the total incidence of VF over a 30-min period is 1a arrhythmias are associated with re-entry [51] , it is not also shown (as a single histogram). possible with present techniques to identify the exact electrophysiological mechanism (re-entry versus flow of 3.3.3.2. Time-course of phase 1 VF onset in conscious injury current, etc.) responsible for the initiation of isprimates. Although human data are not available, there are chaemia-induced VF, whether it be 'phase 1a' or '1b', with data for the conscious baboon [53] . The incidence of VF certainty [52] , or to discriminate between them other than was found to be zero during the first 30 min of ischaemia by inference. Therefore, it may be safer to desist from in this model (Fig. 2b) . However, it would be hazardous to assigning the appellation '1a' or '1b' to VF occurring extrapolate from this observation that phase 1 VF does not during ischaemia in other models if the time-course is occur in man. In fact, the involved zones of the six control observed to be monomodal. It would be safer to call it baboons studied ranged from only 6 to 25% of the total 'monomodal phase 1' VF. An attempt has been made here ventricular weight [53] . In conscious rats or anaesthetised to explore whether or not (i) the pattern of VF seen in the dogs, involved zones of this size would be insufficient to anaesthetised dog (from which the 1a and 1b phase elicit phase 1 VF in accordance with a precise relationship concept was derived) is robust (i.e., consistent between between involved zone size and VF susceptibility different dog studies) and (ii) the pattern is conserved (i.e., [14, 45, 54] . Clearly, the available in vivo primate data is consistent between different species and models versus isolated rat heart. At the other end of the species 4. In evaluating these data, it must be emphasised that spectrum, the conscious rat was reported to exhibit a high species and setting are only two of many possible sources incidence of phase 1 VF early (3-10 min) after the start of of variation. Most laboratories tend to establish their own ischaemia, with a monomodal time-course (Fig. 2c) ; there techniques, with variations in involved zone size, perfusion was no evidence of the bimodal distribution reported for constituents (in vitro models), anaesthetic (in vivo models) the anaesthetised dog [51, 55] . In pentobarbitone-anaesthetas well as species, each potentially contributing to differised rats, the profile was similar, albeit with a slightly ences in outcome. This, together with the fact that the delayed peak (at 5-10 min), and a slightly lower total majority of published studies on the action of drugs do not incidence of VF over 30 min (Fig. 2d) . In a recent study in illustrate the precise natural history of phase 1 VF, makes which rats were thoracotamised and subjected to coronary interpretation of data very difficult. Indeed, even when ligation under brief ether anaesthesia, then monitored studies do illustrate the time-course of VF onset, the ways while conscious, a much lower VF incidence of less than the data are presented are inconsistent and potentially 20% was reported, with all phase 1 VF occurring within 10 misleading. Importantly, the true time-course should take min of the onset of ischaemia [56] . This may be a sexinto consideration 'censoring' by the occurrence of VF (or related anomaly, since, in contrast with most studies, Fig. 3 . Time-course of phase 1 ischaemia-induced VF in different rabbit and pig whole heart preparations, in vivo and in vitro. The methods for obtaining the data, the anaesthetics used (in vivo studies) and other methodological considerations are described in the text. The source material was: reference [62] (part a), [63] (part b), [64] (part c), [20] (part d), [65] (parts e and f), [66] (part g) and [67] (part h). The methods for obtaining the data, the anaesthetics used and other methodological considerations are described in the text. The source material was: reference [69] (part a), [55] (part b), [51] (part c), [67] (part d), [55] (part e), [70] (part f) and [71] (part g). female animals were used [56] , and female rats have been On the other hand, the incidence of ischaemia-induced VF reported to be more resistant to phase 1 VF than males, in is critically dependent on perfusion constituents, species vivo [57] . This profile for the rat in vivo may be contrasted and the type of ischaemia. There are no data available from with that for the rat Langendorff preparation with regional crystalloid perfused hearts from larger species (i.e., dog) ischaemia. In the Langendorff preparation, when involved with which to explore the robustness of these observations. zone size was similar to that produced in vivo, and Limited information from dog hearts perfused with a 1 perfusion K and other factors that determine VF suscepnon-crystalloid blood / Tyrode mix [61] indicated that VF tibility were optimised, the time-course of appearance of occurred during 8 min of regional ischaemia, but that the ischaemia-induced VF was monomodal (like that in rats in incidence was low (31%). vivo) but peak susceptibility was delayed (compared with that in rats in vivo) to 15-20 min (Fig. 2e) . When 3.3.3.5. Time-course of phase 1 VF onset in the rabbit in ischaemia was allowed to persist beyond 30 min in this vivo and in vitro. In anaesthetised rabbits and isolated preparation, the incidence of VF declined over the ensuing rabbit hearts, no consistent pattern has emerged for the 2 h, until no further new episodes appeared [58] . This was time-course of phase 1 VF (Fig. 3a-d ). It is difficult to quite different from the time-course in conscious rats in pinpoint the basis for this variation. In anaesthetised rabbit which, following the waning of phase 1 VF, there occurred studies, Coker [62] , using diazepam, fentanyl and a severe second wave of VF (phase 2 VF) beginning |90 fluanisone anaesthesia, and Bril et al. [63] , using diazepam min after the start of ischaemia [14, 56, 59] . The timing of and pentobarbitone anaesthesia, both reported a monomodthe peak of phase 1 VF in the rat Langendorff preparation al profile of VF, but this was consistent with the original was found to be dependent on sinus rate; it occurred definition of phase 1a VF in only one of the two studies sooner when the heart rate was increased [18] . When [62] . VF incidence peaked 10-15 min after the start of identifiable and established determinants of VF were ischaemia in the other study [63] , exactly at the transition modulated to maximise susceptibility [5, 6, [24] [25] [26] , 90-point between 1a and 1b VF, as described for the anaes-100% of controls experienced VF (Tables 1-3). thetised dog [51, 55] . In contrast, using pentobarbitone anaesthesia, Barrett et al. [64] found a bimodal pattern of 3.3.3.4. Time-course of phase 1 VF onset in primates in VF, although this did not fit with the anaesthetised dog vitro, and in global ischaemia preparations. The timeprofile reported by Kaplinsky et al. [51] and Meesman course for other isolated heart models of ischaemia is less [55] , since the cut-off between the first and second peaks well defined. In regionally ischaemic marmoset hearts occurred 3-5 min after the start of ischaemia (Fig. 3c ) (perfused with a solution similar to that giving a high rather than at 12 min. These data are important for two incidence of VF in rat hearts), and in low flow globally reasons. They show that, even when phase 1 VF is ischaemic rat and guinea pig hearts, there appears to be bimodal, the location of the peaks varies between species. little or no ischaemia-induced VF (Fig. 2f-h) , although, in They also show that there cannot be a universal definition the low flow global ischaemic guinea pig heart, there is of phase 1a and 1b VF based on the precise timing of VF some variation; Gwilt et al. [60] reported a 100% incidence onset since the timing is species-dependent, even when the of VF, a value vastly different from that shown in Fig. 2h . time-course is bimodal. The Gwilt data is not shown in the figure because the In rabbit hearts perfused with a similar solution, and time-course of VF onset was not reported. The low subjected to regional ischaemia of a similar zone size to incidence of ischaemia-induced VF reported in some low that giving a high incidence of VF in regionally ischaemic flow global ischaemia studies may be a consequence of the rat hearts, it was found that the ischaemia-induced VF 1 high K content of the perfusion medium used, 4.6 incidence was zero (Fig. 3d) . Thus, whereas the Langenmequiv. / l in one rat study [9] and 5.8 mequiv. / l in one dorff regionally ischaemic rat hearts differ from the rat in 1 guinea pig study [38] . Equivalent values of K content vivo only in terms of the timing of phase 1 VF, the have been shown to be sufficient to markedly suppress regionally ischaemic rabbit heart appears to differ from the regional ischaemia-induced phase 1 VF in the perfused rat rabbit in vivo in terms of the overall incidence of phase 1 hearts [5] , as discussed earlier. The onset of VF in global VF. However, the different anaesthetic regimen used ischaemia preparations (i.e., in guinea pig hearts), when complicates interpretation of these findings. Moreover, it documented, has been reported to occur later than 15 min could be argued that the perfusion conditions that optimise after the start of ischaemia (Fig. 2h) .
susceptibility to phase 1 VF in the regionally ischaemic rat Thus, one may tentatively propose that, in crystalloid and rabbit heart may differ. Optimum conditions may also perfused hearts from different species, the timing of differ for the marmoset heart, another preparation that ischaemia-induced VF appears to be determined principalappears to be resistant to phase 1 VF during regional ly by the experimental set up per se (i.e., isolated heart ischaemia in vitro (Fig. 2f) . It may be worthwhile to perfusion versus the in vivo setting) and possibly by the explore this possibility, although more information on perfusion constituents used, with the species and type of basal blood levels of major ions in these species would be ischaemia (regional versus global) playing less of a role.
a necessary guide to experimentation. [67] , in and cat. In pig, dog, and cat isolated perfused hearts, there studies that were not controlled for collateral variation, is no clear information on the time-course of ischaemiafound a lower overall incidence of phase 1 VF, and less induced VF (and no data at all for crystalloid perfused well-defined 1a and 1b VF peaks (pentobarbitone anaeshearts from these species, to my knowledge). In pigs in thesia was used in both of these studies; data shown in Fig.  vivo , the outcome of different studies varies in a manner 4c-d). In marked contrast, Meesman [55] found that in similar to that discussed for rabbits, with the exception morphine, chloralose, urethane anaesthetised dogs with that, whereas in some rabbit studies VF occurred no later functional coronary collaterals, phase 1 VF was monomodthan 12 min after the start of ischaemia, in some pig al (Fig. 4e) , and the peak occurred 10-15 min after the studies, VF occurred no earlier than 12 min after the start start of ischaemia (the time of transition between phase 1a of ischaemia. Fig. 3e -f illustrate data from Bardaji et al.
and 1b VF in Fig. 4a-b) . In further contrast, Parratt and [65] that revealed a profile that Meesman et al. [46, 55] Wainwright [70] , using thiopentone and chloralose anaeswould describe as phase 1b VF; the type of anaesthetic thetised greyhounds (collateral status not described), obused (chloralose in Fig. 3e and thiopentone in Fig. 3f ) did served monomodal VF occurring less than 5 min after the not seem to be a major determinant of outcome. In start of ischaemia (Fig. 4f) , a finding similar to that contrast, McDonald et al. [66] , using droperidol, ketamine, described by Penkoske et al. [71] for the cat (a species for pentobarbital, fentanyl and pancuronium anaesthesia, rewhich available time-course data is limited) anaesthetised ported a bimodal profile of phase 1 VF (Fig. 3g) . The with ketamine and chloralose with decamethonium ( Fig.  transition between the first and second peak of VF 4g). In both of these studies, the overall group incidence of occurred some minutes later than the transition in anaes-VF was low (Fig. 4 ). thetised rabbits [63] but sooner than the transition between Conscious dog data is limited. Bolli et al. [54] , in an 'phase 1a' and '1b' VF reported by Kaplinsky et al. [51] elegant experiment that took into account variation in and Meesman [55] for anaesthetised dogs. By further collateral flow, found that no phase 1a VF occurred at all in contrast, Benfey et al. [67] , using pentobarbitone anaescollateral-deficient conscious dogs (during 15 min of thesia, observed a monomodal profile with VF occurring ischaemia), whereas the incidence in equivalent pentobarover a wide time interval (5-25 min; Fig. 3h ), a pattern bitone-anaesthetised dogs was 25%. Susceptibility to phase different from any yet described for any other preparation 1b VF was not explored. These data differ from rat data or species. The pig heart (like that of rat, rabbit and (Fig. 2 ) which indicated that conscious and pentobarmarmoset [20, 37] ) is collateral-deficient [68] , so withinbitone-anaesthetised animals had a similar high incidence species variation in study outcomes cannot be attributed to of VF during the first 15 min of ischaemia. variation in collateral distribution. Indeed, the same conThus, the anaesthetised dog, the preparation for which sideration applies to the rabbit studies discussed earlier.
the 'typical' profile of phase 1 VF was originally defined, One is tempted to suggest, on the basis of data so far actually exhibits a rather inconsistent pattern of ischaemiareviewed that, if ischaemia elicits phase 1a and 1b VF (as induced VF which, in turn, appears to differ from the originally defined) in man, then anaesthetised dogs are profile in the conscious dog. This has important implicasuitable for the study of phase 1a and 1b VF, anaesthetised tions, the most obvious of which is that the value of any pigs are better suited for evaluation of suppression of other model, whether it be in vivo, conscious or anaesthetphase 1b VF, anaesthetised and conscious rats for phase 1a ised, or perfused heart with regional or global ischaemia, VF, anaesthetised rabbits for phase 1a VF, and isolated rat cannot be evaluated for its clinical relevance by appraisal hearts for phase 1b VF. However, without the necessary of the time-course of ischaemia-induced VF using the clinical template, one cannot evaluate this suggestion.
anaesthetised dog as the ''gold standard''. Moreover, one must consider the extent to which the original definition is robust for the dog. Fig. 4 shows six profiles of ischaemia-induced VF in dependent variation. Some of the experiments described anaesthetised dog. As mentioned earlier, the original above may suggest that species is itself an independent description of phase 1a and 1b VF was made using the determinant of susceptibility to ischaemia-induced VF. The anaesthetised preparation, with 12 min of ischaemia as the low incidence of regional ischaemia-induced VF in isocut-off between the phases [46, 51, 55] . However, to illuslated rabbit and marmoset hearts compared with isolated trate this convincingly requires the use of dogs in which rat hearts with equivalent sized involved zones [20, 25] is collateral flow is measured and found to be negligible. one example that supports this notion. These differences Total VF incidence was found by Martin and Meesman are difficult to reconcile. They could be due to a species- [69] to be high, with well differentiated 1a and 1b peaks, dependent relationship between involved zone size and in collateral-deficient dogs ( Fig. 4a ; anaesthetic regime not susceptibility to VF (i.e., a qualitative difference based on specified), although in an earlier and similar study, Meesfundamentally different mechanisms of VF initiation beman [55] reported a lower total incidence of VF (Fig. 4b, tween species). However, this is unlikely since the relationwith morphine, chloralose, urethane anaesthesia). In slight ship between VF incidence and involved zone size in the isolated rat heart [6] is actually qualitatively similar to that 1b VF is not robust, nor is it conserved within or between found in an entirely different model, the anaesthetised dog species and models and, so, it needs to be reconsidered. It preparation with regional ischaemia [45] . The differences would be sensible to restrict the use of the terms phase '1a' could be related to differences in collateral flow, another and '1b' to the VF occurring in anaesthetised dogs with source of variation discussed earlier. Collateral flow in the poor coronary collateralisation. rabbit heart is even lower than that in the rat heart [37] , yet
Nature of, basis for and implications of species-
In the short term, the extent of variation between species the isolated rabbit heart seems to be resistant to developing and models means that labels like 1a and 1b should ischaemia-induced VF [20, 25] . From this, it may be argued perhaps be avoided. Their use lends an apparent importhat some degree of collateral flow is necessary for tance to the twelfth minute of ischaemia that is difficult to maximising susceptibility to ischaemia-induced VF (as justify. It could be the case that the twelfth minute may mentioned earlier). Perhaps collateral flow allows a spatial have relevance only to veterinarians concerned with the dispersion of dysfunction within the involved zone, health of collateral-deficient dogs undergoing general facilitating maintenance of re-entry and, if collateral flow anaesthesia. is too low, then dysfunction within the ischaemic zone When using a model, one should take care to describe may be too homogeneous to facilitate the maintenance of the pattern of phase 1 VF that occurs and state whether it VF. There are some difficulties with this explanation is monomodal or bimodal. If a drug appears to affect however, since VF does develop during regional ischaemia selectively the early or late peak of phase 1 VF, then this in anaesthetised rabbits, as shown in Fig. 3a -c, albeit not should of course be reported. However, a much greater with the same high incidence as seen in the anaesthetised understanding of the scale of variation between models and rat [14] . This indicates that the low incidence of ischaemiaspecies, and the factors that determine this variation, are induced VF in the rabbit Langendorff preparation cannot necessary before findings can be safely extrapolated from be attributed simply to low residual flow.
one model to another and to man. It is possible that the difficulty in explaining the basis
In the longer term, issues will be resolved only when the for this and other examples of species variation is the wider medical community pays more attention to seeking result of complex interplay between different variables. precise and accurate information on the natural history of Rabbit and marmoset hearts, which are only approximately events acutely following coronary obstruction in man, and four-seven and 1.5-2 times the size of the rat's, have a the factors that determine the nature of these events. This ventricular APD and QT that are approximately three times may require the formation of some kind of taskforce to the size of the rat's, yet have an RR interval that is less obtain the information as it pertains to the wider populathan twice as long [20] . If ischaemia-induced VF depends tion at risk of a first attack of cardiac ischaemia (as on flow of injury current for initiation, and re-entry for opposed merely to the survivors of acute ischaemia), since maintenance [72, 73] , these differences might impact greatthe data would otherwise be difficult to obtain. ly on the scope for generation of the ectopic depolarisation that may be necessary for the initiation of VF, and the likelihood of the resultant 'premature' wavefront encoun-4. Model refinement tering sufficient patches of repolarised tissue to allow the fractionation that may be necessary for the maintenance of For any given model, regardless of the characteristics of VF.
the time-course of ischaemia-induced VF, it is important to However, the only safe conclusion to draw from Figs.
control for major sources of variation affecting the inci-2-4 is that the natural history profile of ischaemia-induced dence of VF. This may be simpler to achieve in the VF, and the overall susceptibility to ischaemia-induced VF perfused heart model, since there are fewer variables to (control group incidence), varies between setting (in vivo consider, and most of these can be controlled precisely and versus in vitro), between species and even within species accurately. It is possible to carefully select perfusion (even when data from a single laboratory is considered, in constituents, modify heart rate, chose and obtain different some cases). It is not possible to fully explain this variation involved zone sizes and locations, vary study species with the data presently available. Many sources of variaccording to study objective and even vary the mode of 1 ation (involved zone size, blood K content, collateral perfusion in order to minimise sources of variation, flow, etc.) have been identified and one hopes that if every maximise scope for detecting anti-VF action or address investigator would publish details on these variables for specific questions about VF and its modulation, using their model, it may become possible to construct a species / isolated heart preparations. setting-independent mathematical model of VF initiation that maximises scope for detection of ischaemia-induced consequence of causing bradycardia. It is preferable to VF. This is 3-4 mequiv. / l in the isolated rat heart [5] .
pace at a supraventricular site for this purpose since There is insufficient information at present to comment ventricular pacing has been shown to facilitate ar-
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in general terms on the ideal Ca content of a perfusion rhythmogenesis, presumably by virtue of the creation of a solution. In the rat Langendorff preparation, regional site of ectopic automaticity [74] , although supraventricular ischaemia was found to elicit VF in 100% of control hearts pacing is ineffective in globally ischaemic hearts, due to 11 whether perfused with 1.4 or 2.4 mequiv. / l Ca , althe exacerbation of complete AV block [15] . though the anti-VF effectiveness of a drug with apparent calcium antagonist activity was reduced by the higher 11 11 Ca solution [27] . Thus, Ca , over the range from 5. Detection of antiarrhythmic activity-pitfalls physiological levels to twice that, may not influence phase 11 1 VF susceptibility, although high Ca may be capable of 5.1. Definition of VF surmounting the protective effects of certain drugs.
There are certain difficulties that arise with the measure-4.2. Selection of involved zone size ment of anti-VF activity in isolated hearts that should be avoided. One of these is the problem of arrhythmia Because susceptibility to ischaemia-induced VF is dediagnosis. Many different definitions of VF are given in pendent on the size of the involved region, it is possible to the literature, so inter-study comparisons may be unfeasadjust involved zone size in the regionally ischaemic heart ible. This problem is not restricted to isolated heart models to vary the control incidence of VF [6] . This can be and, even in man, discrimination between VF and other achieved easily and accurately in the isolated heart by ventricular tachyarrhythmias can be hazardous [75] . Carecorrect placement of a coronary ligature [6, 15, 20] . It is ful adherence to the guidelines of the Lambeth Convenpossible to maximise the incidence of ischaemia-induced tions [76] , which provides objective definitions for VF and VF by strategic location of the coronary ligature in all other arrhythmias, can avoid these difficulties. species and preparations in which this has been studied, including the dog in vivo [45] . In the perfused rat heart, a 5.2. Problem of self-terminating VF 40% involved zone size coupled with a 30-min duration of ischaemia maximises scope for susceptibility to VF, with Self-terminating VF occurs commonly in perfused heart an incidence close to 100% in control hearts [6, 15, 20] . In experiments. This probably reflects the fact that almost all theory, it may be possible to explore proarrhythmia by studies have been done using hearts from small animals. aiming for a 20% involved zone size (giving rise to a low Although VF can self-terminate in larger hearts, even in incidence of ischaemia-induced VF [6] ) and perfusing with man [75] , the small size of rat, guinea pig and other hearts putative proarrhythmic drugs, although this type of study used for perfusion is probably a more important basis for has not yet been attempted.
self-termination than the isolated heart perfusion mode of experimentation itself, since self-termination is common 4.3. Regulation of heart rate also in conscious and anaesthetised rats [14] . The relationship between VF cycle frequency, VF duration and QT Heart rate is another source of variation that can be interval has been examined in the isolated rat heart [22] . manipulated to refine the model. Unwanted bradycardia
The data provided evidence that the ability of ischaemiacan occur in perfused hearts for several possible reasons.
induced VF to self-terminate is related to VF wavelength Cardiac cooling, one possible reason, can be overcome in and refractoriness, which supports other evidence that VF regional ischaemia studies by ensuring that the perfusion persists because it is a manifestation of multiple wavelet solution is at 378C when emerging from the aortic cannula re-entry and thus is liable to self-terminate in smaller at a physiologically relevant flow rate. In low flow global hearts [22] . This is not a problem in itself, since VF ischaemia preparations, bradycardia results from SA and initiation (i.e. incidence) is likely to be the most important AV nodal ischaemia, and in zero-flow preparations, this drug target relevant to sudden cardiac death, with VF leads to asystole. Bradycardia can be overcome by insertmaintenance being of less interest (a drug that switches VF ing a small superfusion catheter into the left atrium and off would need to restrict VF to no more than a couple of delivering warm solution. This technique has been shown seconds in man for it to be of any interest, in comparison to maintain orthograde propagation through the AV node, with a drug that prevents VF from occurring in the first as well as maintaining the sinus rate, during global place). A problem has arisen, nevertheless, is that some ischaemia [6] , thereby lending a significant refinement to investigators have chosen to present VF data in ways that the preparation. It is possible to surmount bradycardia by can render interpretation of their observations difficult, for cardiac pacing if the bradycardia is not due to cardiac example, expressing group mean VF duration as a numericooling. Pacing allows testing of whether an anti-VF drug cal value. This is inappropriate since individual values acts 'directly' on VF, or prevents VF as a secondary range from 0 s (i.e., no VF) through finite values (self-terminating VF) to infinity or an arbitrary value (if VF 6.2. Class II and related drugs persists until the end of an observation period) [5] . Thus, if a drug is found to abolish VF in a group of hearts, it would Drugs affecting cardiac adrenoceptor activation have be arcane to suggest that VF duration is reduced to 060 s.
been examined more extensively (Table 1) . The data do There is useful information to be had from monitoring VF not support the idea that block of cardiac adrenoceptor duration but, in order for it to be amenable to analysis that activation prevents ischaemia-induced VF. This has been is both consistent with meaningful enumeration and physexplained in detail by Daugherty et al. [28] . Although beta iological function, it is necessary first to determine VF blockers have some beneficial effect on death rate post incidence, then to determine the proportion of those hearts myocardial infarction in man [77] , there is no good experiencing VF in which at least one episode was evidence that clinical benefit is attributable to suppression sustained [22] . For the rat, a useful arbitrary definition of of ischaemia-induced VF, and the isolated heart data does sustained VF is an episode lasting continuously for 120 s not suggest that such a property, if it exists at all, is or more since, in conscious rats, $120 s of continuous VF substantial. Perhaps this is why the impact of beta blockers will kill the animal, even if sinus rhythm is subsequently on sudden cardiac death is limited (if beta blockers were restored [76] .
truly effective anti-VF agents, then their present widespread use would be having a much greater impact on sudden cardiac death rates).
Need for randomisation and blinded analysis

Class III and related drugs
Even though the isolated heart model is 'simple' in comparison with, for example, a conscious animal model, Even more Class III and related drugs have been tested, there is no justification for disregarding good laboratory but surprisingly, the drugs with the most well established practice. Randomisation to treatment and blinded analysis clinical beneficial effects, amiodarone and sotalol, have not of data are essential. The Lambeth Conventions recombeen tested ( Table 2) . The experiments that have been mended this in 1988 [76] , but few publications actually published do not give a terribly clear picture, with both report the use of these procedures. However, this problem KATP activators and inhibitors reportedly both effective is not just restricted to isolated heart studies. Along with and ineffective in different studies. One would not expect the use of inappropriately high drug doses that are incom-IK blockers to affect ischaemia-induced VF in rat hearts patible with therapeutic administration in conscious because, in this species, the heart does not express humans (see Tables 1-4) , this may be one explanation for functionally important IK currents [78] . Rat heart data may the fact that the number of effective drugs in animal be compared with data from hearts of other species to studies vastly outweighs the number of drugs that actually probe whether IK blockade is an effective mechanism for go on to become clinically useful in the prevention of VF.
VF suppression [25] . Presumably, if a drug that blocks Again, these are not problems restricted to the use of the 1 several K currents suppresses VF and widens QT in the isolated heart. For example, anaesthetised animals can rat heart, then this is a good indication that the drug is not 'tolerate' doses of lignocaine that would evoke convulsions selective for IK, and mediates its effects in the rat by in conscious animals (unpublished observations and [64] ). affecting molecular targets other than IK [79] . It would be worthwhile to explore this contingency for amiodarone and sotalol.
Actions of drugs
Class IV and related drugs
The tables (Tables 1-4 ) describe experiments on VF induced by ischaemia in isolated perfused hearts. The
The effects of Class IV and related drugs are shown in tables are arranged in relation to general drug classes. Table 3 . Again, it is surprising that calcium antagonists have not been tested for effects against left regional 6.1. Class I drugs ischaemia-induced VF in perfused hearts. The same considerations noted for Class I drugs probably apply. Table 3 In Table 1 , it can be seen that there is surprisingly little also shows the effects of miscellaneous interventions. The data on the effects of Class I drugs on ischaemia-induced preconditioning phenomenon appears to protect against VF in isolated hearts. This situation should surely be ischaemia-induced VF in perfused hearts. rectified quickly. It probably reflects the fact that by the Table 4 illustrates studies, in some of which VF was time that the isolated heart was first used for the study of measured only en passant, that reported a low incidence of ischaemia-induced VF, Class I drugs had already been VF in control hearts. More recent studies generally found studied extensively in other models, reducing the level of much higher incidences of VF (Tables 1-3) . interest (and the scope for obtaining the necessary grant It would seem that further work is necessary to charsupport) to test them in the isolated heart. acterise ischaemia-induced VF in perfused hearts in terms of responses to drugs of known pharmacological specificity relevance, all models, techniques and approaches become and selectivity. suspect.
Alternative method of exploring clinical relevance
Possible clinical relevance
In view of the scale of the clinical problem (of sudden cardiac death in its wider context), one cannot simply give 7.1. Method of establishing clinical relevance up the search for anti-VF drugs just because one does not have complete confidence in any experimental preparation. The most difficult issue to address is that of clinical Thus, there has evolved an alternative method for derelevance. Isolated heart preparations allow the generation termining whether or not a preparation is of possible value. of phase 1 ischaemia-induced VF. This allows detection of
The method has never been formalised, and the following anti-VF drug action, and may permit some ancillary attempt to do so is therefore necessary in order to give analysis (of the mechanism of drug action). The preparacontext to the conclusion of this article. tions also allow examination of determinants of VF initiation and maintenance. However, in order to establish 7.2.1. Positive reinforcement (or refute) clinical relevance, one requires a hard clinical Any preparation has a set of characteristics. The closer template with which to refer. This template has two those characteristics appear to resemble the characteristics components, a drug-response profile and a natural history of the human disease, the more comfortable one becomes profile. If any preparation has a drug-response profile that with the preparation. This could be described as positive mirrors the clinical drug-response profile then its natural reinforcement of the preparation. For example, the Lucchhistory profile becomes unimportant.
esi model [82] and the Schwartz-Stone model [83] are two Unfortunately, the clinical relevance of preparations for in vivo models that use a species (dog) with a heart that is detecting anti-VF action relevant to phase 1 cannot be closer to man's in size and anatomy than that of the rat or tested by reference to a current clinical template. We have rabbit, is perfused with blood and has intact innervation no drugs that are proven to prevent phase 1 VF in man, (unlike a Krebs' / Tyrode perfused isolated heart), and use a because, as mentioned earlier, we have no precise or procedure that gives rise to ischaemia in a heart with a accurate information on the time-course of VF suscephealed infarct either at rest [82] or following a period of tibility following coronary obstruction in man. At present, exercise [83] in the conscious setting. These characteristics it is safest to state only that the Class III agents, DL-sotalol are evidently lacking in, for example, an isolated guinea and amiodarone, appear to be beneficial against life-threatpig heart perfused with Krebs' solution and subjected to ening arrhythmias when given to patients who have low flow global ischaemia [38, 84] . The conscious dog survived acute myocardial ischaemia [80] . Importantly, models are therefore positively reinforced whereas the there is no detail on the effectiveness of drugs in people latter is not. who have yet to suffer their first cardiac ischaemic event. The latter may be a difficult problem to address, but its 7.2.2. Negative reinforcement importance must not be disregarded. If ischaemia is severe A preparation can additionally be negatively reinforced. enough to cause cardiac arrest, the survival rate is only For example, any rat heart preparation (in vivo or isolated) about 20% [81] and the most robust clinical data on is negatively reinforced by the lack of functional expresanti-VF drugs is derived from post-infarct studies restricted sion of IK (r or s) in the ventricles [78] . In fact, this is one to these minority of survivors [80] . What of the lost 80% of of the few examples where a preparation has an unpatients, most of whom die out of hospital? Most do not equivocal limitation; clearly, any selective IK blocking contribute to our knowledge about the natural history of agent will not possess antiarrhythmic activity in the rat VF (see earlier) or drug effectiveness for the prevention of heart [79] , albeit, until it is clear beyond doubt that IK VF, because they die before being seen by a physician.
blockade can reduce ischaemia-induced VF in man, this Thus, a clinical template for evaluating the appropriateness apparent limitation remains theoretical. of animal models can be anticipated, paradoxically, only
The differences between preparations in terms of the when drugs are available that can be used prophylactically natural history of arrhythmogenesis also gives cause for to prevent out-of-hospital VF. This makes any attempt to negative reinforcement of a preparation. However, unless evaluate a model by reference to a clinical template of one is certain which preparation is 'correct', then the drug effectiveness unfeasible. existence of a difference can be regarded as no more than a The absence of either a clear-cut drug-response profile cause for concern. There is certainly much variation in or natural history profile has hampered anti-VF drug phase 1 VF natural history, as shown in Figs. 2-4 and development, because it prevents elucidation of the clinical discussed earlier. In addition, phase 2 VF, the second relevance of not just isolated hearts but, in fact, all animal major peak [14] that appears about 90 min after permanent models. Without proven legitimacy in terms of clinical occlusion and lasts for at least another 3 h, is completely absent in the rat Langendorff preparation [58] . The safest disadvantages. The reasons for this are intriguing, and are way of interpreting these data is to regard the presence of discussed further in the following section. differences as negatively reinforcing all models to some extent.
If individual isolated heart studies are considered, it is 8. Recommendations evident that some data provide positive reinforcement, and some negative. As an example of positive reinforcement, 8.1. Choosing an isolated heart preparation 1 phase 1 VF is clearly reduced by raising the K concentration in the solution delivered to the uninvolved If isolated heart preparations are to be used for detecting region of the perfused regionally ischaemic rat heart new anti-VF drugs or exploring the pathophysiology of [5, 29] . This effect parallels the inverse relationship be-VF, then the model refinements described earlier may be of 1 tween blood K and sudden cardiac death in man [42] [43] [44] . value. In a broader context, it may be worthwhile to As an example of negative reinforcement, verapamil, a consider where the preparations may fit into the context of drug that has had no impact on sudden cardiac death [77] , drug discovery. can suppress VF in the guinea pig low flow ischaemia
No new drug today is simply a random screened preparation [60] . These, and other numerous equivalent chemical. Drugs are designed to have specific molecular examples, are interesting, but none alone are sufficient to actions (on molecular targets such as receptors, enzymes condemn any model or approach.
and ion channels). In drug development, animal models are needed to provide preclinical information on whether or 7.2.3. Current practice not there is a reasonable chance that the drug may work to It is evident from this that positive and negative treat a disease. Thus, if it is the case that phase 1 VF reinforcement cannot provide scientifically acceptable contributes to sudden cardiac death in man, then animal proof of the absolute (or even relative) merit of different models are needed to permit detection of suppression of preparations. A selection of the examples highlighted in this form of VF. If a drug is synthesised and shown to this section might lead a naive investigator to conclude that affect a specific molecular target, then the choice of the Lucchesi or Schwartz-Stone dog models should be preparation can be made rationally on the basis of knowlused to detect new anti-VF drugs, and the isolated heart edge of the expression of the molecular target in the heart should never be used. Indeed, until the 1990s, the literature of a given species, and the utility of the species as a gives the impression that this was an accepted consensus.
bioassay for detecting anti-VF action. Yet, these conscious dog models are now used infrequentIf the molecular target is expressed in the rat, then the ly. The reasons for this is unclear. Cost may be a factor. bioassay characteristics of the regional ischaemia LangenHowever, the models have not yet been proven to be the dorff preparation, and the growing data base for this most clinically relevant in absolute terms. For this to be so, preparation, make it ideal for first line use. The overthey would need to meet the criteria of being uniquely able whelming dominance of this preparation among isolated to allow detection of the beneficial effects of a drug that is heart options (see Tables 1-4) , and the increase in its use also effective in man against sudden cardiac death and as the use of other preparations declines, attest to the uniquely able to predict ineffectiveness and the detrimental increasing perception of its utility. However, popularity effects of proarrhythmic drugs. It is not feasible to attempt does not necessarily equate with appropriateness, and to review all data with conscious dog models here, but, parallels with politics may be made -popular new suffice to state, these criteria are not met (if they were, governments are commonly voted out of office the next then the present crisis in confidence in anti-VF drug time an election takes place. development, and the requirement for articles such as this, The guinea pig low flow global ischaemia preparation would not exist). On the other hand, the isolated heart has may be used as an alternative if the molecular target is not emerged as a system for detecting anti-VF action of drugs functionally expressed in rat heart. This is particularly (Tables 1-4) . The reason for this is unclear. Again, cost relevant if the target is IK. However, more work is may be a factor. However, the facility for rapid data required to standardise the preparation, since there is some generation and the versatility of the model means that it variation in the incidence of phase 1 VF between studies, can be possible not only to detect anti-VF activity but also ranging from 100% [60] to 30% [85] . to ascertain concentration-response relationships and likely mechanisms of action at the molecular and cellular 8.2. False positives and false negatives level. This means that, provided that the drug's molecular target is expressed in the human heart, then the data itself
The two main limitations of isolated heart preparations provides positive reinforcement of the preparation. Conare the same as those for any other preparation or model: cern about absolute clinical relevance seems not to be a potential for failure to detect protective actions of potenmajor issue, nor can it be as yet. The advantages of tially clinically useful drugs (false negatives), and the isolated hearts are clearly perceived to outweigh the potential for generation of false positives. With regard to false negatives, until it is possible to show that the commensurate with relative selectivity for the intended molecular or cellular mechanisms responsible for phase 1 molecular target. On the basis of experimental and clinical VF are categorically different in man from those causing data with lignocaine, it may be argued that although the the same VF in an animal preparation, then one cannot isolated heart data suggest that the sodium channel may legislate for false negatives as a generality.
represent a viable molecular target for phase 1 VF suppresSpecifically, one would expect a false negative if the sion, consideration of in vivo (ideally conscious) animal drug's molecular target is not expressed in the preparation model data is required before the efficacy (safety as well as (this point has already been addressed). The likelihood of effectiveness) of sodium channel blockade itself can be false negatives as a generality may be low for two reasons.
predicted from animal studies. Moreover, the fact that (i) The occurrence of phase 1 VF, although uncertain in lignocaine at 10 mM suppresses ischaemia-induced VF in man, is common to most species, regardless of whether it guinea pig hearts subjected to global ischaemia [60] yet is mono-or bimodal in time-distribution. This implies that, fails to prevent sudden cardiac death in man [77] hardly although quantitative differences may exist in terms of condemns the isolated heart as an experimental model; the mechanisms of arrhythmogenesis between species, there is real conclusion from the available isolated heart data is a qualitative similarity, so the chance that man is uniquely that it would be a good idea to perform some concentration different would be expected to be low. (ii) There are no response studies with a few Class I drugs to test their known examples of interventions that fail to work in any effectiveness against VF induced by regional ischaemia, animal preparation yet reduce sudden cardiac death in man.
something that has unaccountably not been done (Table 1) . Nevertheless, as a cautionary note, the two publications from which one may derive the time-course of ischaemia-8. 3 . Putting the data into context induced VF in primate hearts reported negligible phase 1 VF in vitro [20] and a complete absence in vivo [53] . If
This leads on to an important recommendation. It would one argues that primates are more clinically relevant than be foolish to take a drug tested only in isolated hearts into any other animals, then it could be argued that ischaemiaa clinical trial. It is necessary as an intermediate step to induced VF may not occur at all in man. This is probably obtain in vivo (ideally conscious) animal model data. an unreasonable proposition, however, since involved zone However, one might ask why bother with isolated heart size was very low in the in vivo primate study cited (as studies if in vivo animal experimentation is a necessary discussed earlier), whereas the perfused primate heart next step? The answer is simple. In vivo (especially study cited [20] may have been flawed in some other way conscious) animal models are not viable for first line (by the use of non-optimal perfusion constituents, pertesting of every new drug. Animal studies in vivo are haps).
time-consuming and technically demanding, and can be False positives are a much greater likely source of expensive, whereas isolated heart studies are simple to misleading information. The possibility of false positives perform and may quickly provide abundant and extensive can be explored by comparing the actions of 'old' drugs in information on the potential effectiveness and concenisolated heart preparations with their actions in man. The tration-dependence of a drug's action. The bottom line is most reliable drug for making this comparison is ligthat, if a drug is effective in an isolated heart preparation nocaine because it has been used clinically for many years that expresses the drug's specific molecular target, it may and the data, which clearly indicates a lack of benefit be worth carrying out in vivo animal studies, provided that against sudden cardiac death in man, are unequivocal [77] .
an effect is achieved with a pharmacological (as opposed Unfortunately, lignocaine has been studied only once for to a toxicological) drug concentration -as a rule of its effects on ischaemia-induced VF in perfused hearts; it thumb, no more than 1 mM, and ideally no more than 0.1 was effective at 10 mM in the guinea pig low flow global mM. Recent development of the Class III drug, tedisamil, ischaemia preparation [60] . The reason for this false typifies this approach. Its actions on phase 1 arrhythmias positive may be attributable to an inappropriately high were examined several years ago in the rat Langendorff drug concentration. It is unfeasible to expect a plasma regional ischaemia preparation [22] . The data, together protein-unbound concentration of 10 mM lignocaine to be with more encouraging data from the conscious rat with maintained throughout the period that a human might be regional ischaemia [86] , prompted further studies which susceptible to phase 1 VF, let alone be maintained during only recently culminated in the testing of the drug in the the period when other arrhythmias associated with corLucchesi dog model [87, 88] . onary artery disease (i.e., phase 2 and reperfusion-induced For the future, hearts from transgenic animals (par-VF) occur.
ticularly rats, for which there is a large non-transgenic False positives, therefore, are easily achieved in isolated database) expressing human molecular targets may reprehearts by virtue of the fact that drug concentrations may be sent an ideal solution to the possible species-related elevated with equanimity to any level, short of that limitations of isolated heart preparations. eliciting AV block or asystole. It is important therefore that There is one further consideration that may be of great drugs be tested only over the concentration range that is relevance. What if clinical data is eventually obtained that reveals that man exhibits separate 1a and 1b phases of VF, Dr PK Moore, Dr A Farkas, Dr SA Rees and Dr KH and exhibits phase 2 VF and clinically important reBanner are thanked for proof-reading the manuscript. perfusion-induced VF, each potentially contributing to sudden cardiac death? If these different manifestations of VF occur via discrete mechanisms in man, then no single
